-
Discriminative validity of a substance use symptom checklist for moderate-severe DSM-5 cannabis use disorder (CUD) in primary care settings.
Hamilton LK, Bradley KA, Matson TE, Lapham GT. Discriminative validity of a substance use symptom checklist for moderate-severe DSM-5 cannabis use disorder (CUD) in primary care settings. Drug and Alcohol Dependence Reports 2024;12:100260.
-
Predictors of urine toxicology and other biologic specimen missingness in randomized trials of substance use disorders.
Kelley AT, Incze MA, Baumgartner M, Campbell ANC, Nunes EV, Scharfstein DO. Predictors of urine toxicology and other biologic specimen missingness in randomized trials of substance use disorders. Drug and Alcohol Dependence 2024;261:111368.
-
Extended-release 7-day injectable buprenorphine for patients with minimal to mild opioid withdrawal.
D'Onofrio G, Herring AA, Perrone J, Hawk K, Samuels EA, Cowan E, Anderson E, McCormack R, Huntley K, Owens P, Martel S, Schactman M, Lofwall MR, Walsh SL, Dziura J, Fiellin DA. Extended-release 7-day injectable buprenorphine for patients with minimal to mild opioid withdrawal. JAMA Network Open 2024;7(7):e2420702.
-
Barriers and facilitators to using a clinical decision support tool for opioid use disorder in primary care: Insights from clinicians and clinic leaders.
Hooker SA, Solberg LI, Miley KM, Borgert-Spaniol C, Rossom RC. Barriers and facilitators to using a clinical decision support tool for opioid use disorder in primary care: Insights from clinicians and clinic leaders. Journal of the American Board of Family Medicine 2024;37(3):389-398.
-
Assessing substance use disorder symptoms with a checklist among primary care patients with opioid use disorder and/or long-term opioid treatment: An observational study.
Williams EC, Matson TE, Hallgren KA, Oliver M, Wang X, Bradley KA. Assessing substance use disorder symptoms with a checklist among primary care patients with opioid use disorder and/or long-term opioid treatment: An observational study. Journal of General Internal Medicine 2024;39:2169-2178.
-
Predictability of buprenorphine-naloxone treatment retention: A multi-site analysis combining electronic health records and machine learning.
Haredasht FN, Fouladvand S, Tate S, Chan MM, Yeow JJL, Griffiths K, Lopez I, Bertz JW, Miner AS, Hernandez-Boussard T, Chen CA, Den H, Humphreys K, Lembke A, Vance LA, Chen JH. Predictability of buprenorphine-naloxone treatment retention: A multi-site analysis combining electronic health records and machine learning. Addiction 2024;119(10):1792-1802.
-
“To prescribe or not to prescribe, that is the question:” Perspectives on opioid prescribing for chronic, cancer-related pain from clinicians who treat pain in survivorship.
Bulls HW, Hamm M, Wasilewski J, Olejniczak D, Bell SG, Liebschutz JM. "To prescribe or not to prescribe, that is the question": Perspectives on opioid prescribing for chronic, cancer-related pain from clinicians who treat pain in survivorship. Cancer 2024;130(17):3034-3042.
-
Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trial.
Shulman M, Provost SE, Ohrtman K, Novo P, Meyers-Ohki S, VanVeldhuisen PC, Oden N, Otterstatter M, Bailey GL, Liu D, Rotrosen J, Nunes EV, Weiss RD. Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trial. Contemporary Clinical Trials 2024;142:107543.
-
Wiidookaage’win: Beta-test of a Facebook group intervention for Native women to support opioid use recovery.
Roche AI, Young A, Sabaque C, Kelpin SS, Sinicrope P, Pham C, Marsch LA, Campbell ANC, Venner KL, Baker-DeKrey L, Wyatt T, WhiteHawk S, Nord T, Resnicow K, Young C, Brown A, Bart G, Patten C. Wiidookaage'win: Beta-test of a Facebook group intervention for Native women to support opioid use recovery. Journal of Substance Use and Addiction Treatment 2024;163:209396.
-
Wiidookaage’Win: A community-based qualitative approach to developing a Facebook group intervention for Native women to support recovery from opioid use.
Young A, Sinicrope P, Kelpin S, Roche AI, Sabaque C, Pham C, Marsch LA, Campbell ANC, Venner KL, Bastian E, Nord T, Mason G, Baker L, Wyatt T, Fish A, Bart G, Patten C. Wiidookaage'Win: A community-based qualitative approach to developing a Facebook group intervention for Native women to support recovery from opioid use. American Journal of Health Promotion 2024;38(2):205-218.